⌘K

Login Start Free

Home/Filings/4/0000899243-23-005242

4//SEC Filing

Hamdy Ahmed MD 4

Accession 0000899243-23-005242

CIK 0001796129other

View on SEC.gov Company Profile

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 4:05 PM ET

Size

5.5 KB

Accession

0000899243-23-005242

Insider Transaction Report

Form 4

Period: 2023-02-15

Vincerx Pharma, Inc.VINC

DirectorPresident and CEO10% Owner

Transactions

Award
Stock Option (right to buy)
2023-02-15+90,000→ 90,000 total
Exercise: $1.17Exp: 2033-02-14→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]Option vests in twenty-four equal monthly installments starting from February 15, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vincerx Pharma, Inc.

CIK 0001796129

Entity typeother

Related Parties

1

filerCIK 0001458506

Filing Metadata

Form type: 4
Filed: Feb 15, 7:00 PM ET
Accepted: Feb 16, 4:05 PM ET
Size: 5.5 KB

View on SEC.gov